Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer

SIMPLE SUMMARY: Circulating tumour DNA profiling can cost-efficiently accelerate biomarker discovery within oncology trials. However, biomarker identification in metastatic castration-resistant prostate cancer is confounded by a heterogeneous genomic landscape with few commonly-perturbed genes and a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Autores principales: De Laere, Bram, Crippa, Alessio, Mortezavi, Ashkan, Ghysel, Christophe, Rajan, Prabhakar, Eklund, Martin, Wyatt, Alexander, Dirix, Luc, Ost, Piet, Grönberg, Henrik, Lindberg, Johan
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8037684/
https://ncbi.nlm.nih.gov/pubmed/33808193
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071588
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares